Literature DB >> 9858706

Fgf-R3 is expressed in a subset of chicken spinal motorneurons.

J M Philippe1, A Garces, O deLapeyière.   

Abstract

The expression pattern of the fibroblast growth factor receptor Fgf-R1, R2 and R3 genes was studied in the chicken spinal cord using in situ hybridization (ISH). Unlike Fgf-R1 which is widely expressed in motoneurons, Fgf-R3 is expressed in a subset of motoneurons in the medial subdivision of the median motor column (MMCm) that also express Islet-1 and Lim-3. The motoneuron identity of the labelled cells was confirmed by double ISH and by single cell RT-PCR. Interestingly, E3.5 spinal cord motoneurons do not express Fgf-R3, suggesting the expression of Fgf-R3 in motoneurons begins with axonal growth. Copyright 1998 Elsevier Science Ireland Ltd. All Rights Reserved

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9858706     DOI: 10.1016/s0925-4773(98)00158-0

Source DB:  PubMed          Journal:  Mech Dev        ISSN: 0925-4773            Impact factor:   1.882


  4 in total

Review 1.  Molecular mechanisms regulating motor neuron development and degeneration.

Authors:  T J Kilpatrick; M Soilu-Hänninen
Journal:  Mol Neurobiol       Date:  1999-06       Impact factor: 5.590

2.  Guidance of postural motoneurons requires MAPK/ERK signaling downstream of fibroblast growth factor receptor 1.

Authors:  Prabakaran Soundararajan; James P Fawcett; Victor F Rafuse
Journal:  J Neurosci       Date:  2010-05-12       Impact factor: 6.167

3.  NEUROG2 drives cell cycle exit of neuronal precursors by specifically repressing a subset of cyclins acting at the G1 and S phases of the cell cycle.

Authors:  Marine Lacomme; Laurence Liaubet; Fabienne Pituello; Sophie Bel-Vialar
Journal:  Mol Cell Biol       Date:  2012-04-30       Impact factor: 4.272

4.  Fibroblast growth factor receptor 3 signaling regulates the onset of oligodendrocyte terminal differentiation.

Authors:  Luke Y S Oh; Adam Denninger; Jennifer S Colvin; Aditee Vyas; Shubha Tole; David M Ornitz; Rashmi Bansal
Journal:  J Neurosci       Date:  2003-02-01       Impact factor: 6.167

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.